Furthermore, the combination of anti-OPN mAb with Ara-C chemotherapy into acute lymphoblastic leukemia (ALL) engrafted mice showed a higher effect on the reduction of leukemic burden compared with Ara-C alone [32]. Here, SPP1 is linked to acute lymphoblastic leukemia.